免疫檢測市場規模、佔有率及成長分析（按產品、技術、檢體、應用、最終用戶和地區）－2025-2032 年產業預測

預計到 2023 年免疫檢測市場規模將達到 358 億美元，從 2024 年的 380.6 億美元成長到 2032 年的 620.4 億美元，預測期內（2025-2032 年）的複合年成長率為 6.3%。

全球免疫檢測市場正在經歷強勁成長，這得益於技術進步、診斷測試需求的增加以及臨床診斷、環境測試和生物製藥等多樣化應用。但這種成長受到檢測變異性以及開發新型免疫測量的複雜性和成本等挑戰的限制。技術創新需要大量投資，這為市場進入設置了障礙。然而，個人化醫療的日益成長的趨勢正在推動免疫測量的使用，並且來自公共和私營部門的增加的研究津貼正在為市場進入創造機會。總體而言，儘管市場面臨一定的障礙，但市場擴張的潛力仍然很高，特別是滿足不斷變化的醫療保健需求和市場動態。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 專利分析

免疫檢測市場規模：按產品

• 市場概覽
• 試劑和套件
  • ELISA 試劑和套件
  • CLIA 試劑和套件
  • IFA試劑和套件
  • 快速檢測試劑和套件
  • ELISpot 試劑和套件
  • 蛋白質印跡試劑和套件
  • 其他試劑和套件
• 分析儀
  • 按類型
  • 開放式系統
  • 封閉式系統
  • 按購買方式
  • 租賃購買
  • 完成購買

免疫檢測市場規模：依技術分類

• 市場概覽
• ELISA
• 化學冷光免疫檢測（CLIA）
• 螢光試驗（IFA）
• 快速檢測
• 橢圓光斑
• 西方印漬術
• 其他技術

免疫檢測市場規模（按檢體）

• 市場概覽
• 血
• 唾液
• 尿
• 其他標本

免疫檢測市場規模：按應用

• 市場概覽
• 感染疾病
• 內分泌學
• 腫瘤學
• 骨骼和礦物質疾病
• 心臟病學
• 血液檢查
• 自體免疫疾病
• 過敏診斷
• 毒理學
• 新生兒篩檢
• 其他用途

免疫檢測市場規模（按最終用戶分類）

• 市場概覽
• 醫院和診所
• 臨床實驗室
• 製藥/生物技術公司和 CRO
• 血庫
• 研究與學術研究所
• 居家照護環境

免疫檢測市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Abbott Laboratories（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Thermo Fisher Scientific Inc.（USA）
• Siemens Healthineers AG（Germany）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Bio-Rad Laboratories, Inc.（USA）
• QIAGEN NV（Germany/Netherlands）
• Sysmex Corporation（Japan）
• Merck KGaA（Germany）
• DiaSorin SpA（Italy）
• bioMerieux SA（France）
• QuidelOrtho Corporation（USA）
• Agilent Technologies, Inc.（USA）
• Hologic Inc.（USA）
• PerkinElmer, Inc.（USA）
• Luminex Corporation（USA）
• Autobio Diagnostics Co., Ltd.（China）
• Beckman Coulter, Inc.（USA）
• Randox Laboratories（UK）

結論和建議

Immunoassay Market size was valued at USD 35.8 billion in 2023 and is poised to grow from USD 38.06 billion in 2024 to USD 62.04 billion by 2032, growing at a CAGR of 6.3% during the forecast period (2025-2032).

The global immunoassay market is experiencing robust growth, driven by technological advancements, heightened demand for diagnostic testing, and diverse applications in clinical diagnostics, environmental testing, and biopharmaceuticals. This growth is tempered by challenges such as assay variability and the complexities and costs associated with developing novel immunoassays. Significant investments are essential for innovation, which can create barriers to market entry. However, opportunities are emerging, particularly with the increasing trend toward personalized medicine that boosts the usage of immunoassays, along with rising funding from both private and public sectors for research initiatives. Overall, while the market faces certain hurdles, the potential for expansion remains strong, particularly in response to evolving healthcare needs and market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Immunoassay Market Segments Analysis

Global Immunoassay Market is segmented by Product, Technology, Specimen, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits and Analyzers. Based on Technology, the market is segmented into ELISA, Chemiluminescence Immunoassay (CLIA), Immunofluorescence assay (IFA), Rapid Tests, ELISpot, Western Blotting and Other Technologies. Based on Specimen, the market is segmented into Blood, Saliva, Urine and Other Specimens. Based on Application, the market is segmented into Infectious Diseases, Endocrinology,Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening and Other Applications. Based on End User, the market is segmented into Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Banks, Research & Academic Laboratories and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Immunoassay Market

The immunoassay market is being significantly propelled by increased funding from both governmental bodies and organizations aimed at advancing healthcare research and development. This surge in financial support is fostering the creation and enhancement of advanced immunoassay technologies. Additionally, heightened investments from the private sector, particularly in therapeutic and diagnostic research, are further stimulating demand and innovation within the immunoassay field. As a result, the combination of private sector contributions and proactive government initiatives plays a crucial role in driving the growth and evolution of the immunoassay market.

Restraints in the Immunoassay Market

The immunoassay market faces significant constraints in certain developing regions due to inadequate healthcare infrastructure and a lack of awareness regarding immunoassay techniques. This limited understanding hampers the market's growth potential, as there is an increasing need for education and training on these methodologies, which can be both challenging and costly to implement. Additionally, the shortage of skilled professionals capable of interpreting results and effectively operating immunoassay systems further limits the adoption and demand for these technologies. Consequently, these factors collectively impede the overall expansion of the immunoassay market in these areas.

Market Trends of the Immunoassay Market

The immunoassay market is witnessing significant growth, driven by the expanding applications across various sectors. With the increasing prevalence of infectious and chronic diseases, there is a heightened demand for immunoassays for effective disease monitoring and detection. The biopharmaceutical industry particularly fuels this trend, as these assays are essential for therapeutic monitoring and drug development. Additionally, the rising focus on environmental safety has led to a growing need for immunoassays to detect contaminants, further broadening their application scope. As a result, the market is poised for robust growth, reflecting the versatility and critical role of immunoassays in healthcare and environmental contexts.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Patent Analysis

Global Immunoassay Market Size by Product & CAGR (2025-2032)

• Market Overview
• Reagents & Kits
  • ELISA Reagents & Kits
  • CLIA Reagents & Kits
  • IFA Reagents & Kits
  • Rapid Test Reagent & Kits
  • ELISpot Reagent & Kits
  • Western Blot Reagent & Kits
  • Other Reagents & Kits
• Analyzers
  • By Type
  • Open-ended Systems
  • Closed-ended Systems
  • By Purchase Mode
  • Rental Purchase
  • Outright Purchase

Global Immunoassay Market Size by Technology & CAGR (2025-2032)

• Market Overview
• ELISA
• Chemiluminescence Immunoassay (CLIA)
• Immunofluorescence assay (IFA)
• Rapid Tests
• ELISpot
• Western Blotting
• Other Technologies

Global Immunoassay Market Size by Specimen & CAGR (2025-2032)

• Market Overview
• Blood
• Saliva
• Urine
• Other Specimens

Global Immunoassay Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infectious Diseases
• Endocrinology
• Oncology
• Bone & Mineral Disorders
• Cardiology
• Blood Screening
• Autoimmune Disorders
• Allergy Diagnostics
• Toxicology
• Newborn Screening
• Other Applications

Global Immunoassay Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies and CROs
• Blood Banks
• Research & Academic Laboratories
• Home Care Settings

Global Immunoassay Market Size & CAGR (2025-2032)

• North America (Product, Technology, Specimen, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Specimen, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Specimen, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Specimen, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Specimen, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany/Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autobio Diagnostics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations